Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Editas Medicine, Inc. | 106,610 | reported | 11 May 2023 | tx 25+529,050−23,163 |
| Verastem, Inc. | 52,666 | reported | 21 May 2026 | tx 11+333,950−5,291 |
| GERON CORP | 27,500 | reported | 18 Feb 2026 | tx 9+4,903,500−37,355 |
| MOMENTA PHARMACEUTICALS INC | 6,813 | reported | 25 Oct 2019 | tx 11+150,620−31,196 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | GRANT_AWARD | Verastem, Inc. | 36,000 | 0.00 USD | |
| 18 Feb 2026 | SALE | GERON CORP | 9,855 | 1.94 USD | |
| 18 Feb 2026 | EXERCISE | GERON CORP | 27,500 | 0.00 USD | |
| 18 Feb 2026 | EXERCISE | GERON CORP | 27,500 | 0.00 USD | deriv |
| 17 Feb 2026 | GRANT_AWARD | GERON CORP | 1,660,000 | 0.00 USD | deriv |
| 22 May 2025 | GRANT_AWARD | Verastem, Inc. | 8,333 | 0.00 USD | |
| 22 May 2025 | GRANT_AWARD | Verastem, Inc. | 12,500 | 0.00 USD | deriv |
| 18 Feb 2025 | GRANT_AWARD | GERON CORP | 110,000 | 0.00 USD | deriv |
| 18 Feb 2025 | GRANT_AWARD | GERON CORP | 656,000 | 0.00 USD | deriv |
| 18 Jun 2024 | GRANT_AWARD | Verastem, Inc. | 8,333 | 0.00 USD | |
| 18 Jun 2024 | GRANT_AWARD | Verastem, Inc. | 12,500 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | GERON CORP | 250,000 | 0.00 USD | deriv |
| 11 Mar 2024 | GRANT_AWARD | Verastem, Inc. | 5,291 | — | deriv |
| 11 Mar 2024 | OTHER | Verastem, Inc. | 5,291 | — | deriv |
| 14 Feb 2024 | GRANT_AWARD | GERON CORP | 850,000 | 0.00 USD | deriv |
| 25 Sept 2023 | GRANT_AWARD | GERON CORP | 1,350,000 | 0.00 USD | deriv |
| 15 May 2023 | GRANT_AWARD | Verastem, Inc. | 62,500 | 0.00 USD | deriv |
| 11 May 2023 | SALE | Editas Medicine, Inc. | 949 | 9.87 USD | |
| 02 Mar 2023 | GRANT_AWARD | Editas Medicine, Inc. | 31,500 | 0.00 USD | |
| 03 Mar 2023 | SALE | Editas Medicine, Inc. | 184 | 8.89 USD | |
| 02 Mar 2023 | GRANT_AWARD | Editas Medicine, Inc. | 94,500 | 0.00 USD | deriv |
| 13 Feb 2023 | SALE | Editas Medicine, Inc. | 4,287 | 9.67 USD | |
| 10 Jan 2023 | SALE | Editas Medicine, Inc. | 1,752 | 8.16 USD | |
| 05 Dec 2022 | SALE | Editas Medicine, Inc. | 193 | 10.23 USD | |
| 06 Sept 2022 | SALE | Editas Medicine, Inc. | 192 | 15.01 USD |